SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Novo Nordisk Seeks US and EU Approval for Sickle Cell Drug Etavopivat

Novo Nordisk submitted the drug for approval in the US and EU.

Story updates

11:09:09 AM UTC
SquawkNews
Novo Nordisk announces the submission of a New Drug Application to the FDA and a Marketing Authoriza

Related stories